Instituto de Investigaciones Biomédicas "Alberto Sols", Consejo Superior de Investigaciones Científicas (CSIC), Universidad Autónoma de Madrid, Madrid (UAM), Spain.
Unidad de Tumores Endocrinos (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Thyroid. 2022 Oct;32(10):1259-1270. doi: 10.1089/thy.2022.0163. Epub 2022 Aug 16.
The sodium/iodide symporter (NIS) is a transmembrane protein located on the basolateral membrane of thyrocytes. Despite its physiological and clinical relevance, little is known about the mechanisms that mediate NIS subcellular sorting. In the present study, we examined NIS basolateral trafficking using non-thyroid and thyroid epithelial cells. Immunofluorescence and Western blotting were performed to analyze NIS subcellular location and function in cells grown in monolayers under unpolarized and/or polarized conditions. Strategic NIS residues were mutated, and binding of NIS to clathrin adaptor complexes was determined by immunoprecipitation. We show that NIS reaches the plasma membrane (PM) through a thyrotropin-dependent mechanism 24 hours after treatment with the hormone. We demonstrate that NIS basolateral trafficking is a clathrin-mediated mechanism, in which the clathrin adaptor complexes AP-1 (A and B) sort NIS from the -Golgi network (TGN) and recycling endosomes (REs). Specifically, we show that the AP-1B μ1 subunit controls NIS basolateral sorting through common REs. In its absence, NIS is apically missorted but remains functional. Additionally, direct NIS basolateral transport from the TGN to the basolateral membrane is mediated by AP-1A through clathrin-coated vesicles that also carry the transferrin receptor. Loss of the μ1 subunit of AP-1A is functionally compensated by AP-1B. Furthermore, loss of both subunits diminishes NIS trafficking to the PM. Finally, we demonstrate that AP-1A binds to the L121 and LL562/563 residues on NIS, whereas AP-1B binds to L583. Our findings highlight the novel involvement of the clathrin-coated machinery in basolateral NIS trafficking. Given that AP-1A expression is reduced in tumors, and its expression correlates with that of NIS, these findings will help uncover new targets in thyroid cancer treatment.
钠/碘转运体(NIS)是一种位于甲状腺细胞基底外侧膜的跨膜蛋白。尽管其具有生理和临床相关性,但对于介导 NIS 亚细胞分拣的机制知之甚少。在本研究中,我们使用非甲状腺和甲状腺上皮细胞研究了 NIS 的基底外侧转运。通过免疫荧光和 Western blot 分析了在非极化和/或极化条件下单层培养的细胞中 NIS 的亚细胞位置和功能。突变了 NIS 的关键残基,并通过免疫沉淀测定了 NIS 与网格蛋白衔接复合物的结合。我们发现,NIS 在激素处理 24 小时后通过促甲状腺激素依赖性机制到达质膜(PM)。我们证明 NIS 的基底外侧转运是一种网格蛋白介导的机制,其中网格蛋白衔接复合物 AP-1(A 和 B)将 NIS 从高尔基体网络(TGN)和再循环内体(RE)分拣出来。具体来说,我们表明 AP-1B μ1 亚基通过共同的 RE 控制 NIS 的基底外侧分拣。在缺乏 μ1 亚基的情况下,NIS 被错误分拣到顶侧,但仍保持功能。此外,AP-1A 通过网格蛋白包被小泡直接从 TGN 向基底外侧膜转运 NIS,这些小泡还携带转铁蛋白受体。AP-1A 的 μ1 亚基的缺失被 AP-1B 功能上补偿。此外,两个亚基的缺失均会降低 NIS 向 PM 的转运。最后,我们证明 AP-1A 结合到 NIS 的 L121 和 LL562/563 残基上,而 AP-1B 结合到 L583 上。我们的研究结果强调了网格蛋白包被机制在 NIS 基底外侧转运中的新作用。鉴于 AP-1A 在肿瘤中的表达减少,并且其表达与 NIS 相关,这些发现将有助于发现甲状腺癌治疗的新靶点。